Reaching the next level for RWE applications in pharma

White Paper

Reaching the next level for RWE applications in pharma

presented by SAS


Real-world evidence (RWE) has become a significant catalyst for health economics and outcomes research (HEOR), external control arms, trial feasibility and more. And as artificial intelligence (AI) technologiesmature, they’re further expediting what’s possible in the realm of RWE. Read the ebook to learn more about the promise of RWE in life sciences and why current trends influencing data, math and computational power are helping to catalyze RWE in ways previously thought impossible.

Have we reached an inflection point for the potential of real-world evidence (RWE) in life sciences? Experts think so. Read the white paper to understand the factors catalyzing RWE and what it could mean for your organization.